About this conference
ICPMDT is a 1-day conference in Sydney, Australia on 27 Jan 2027. Abstract deadline: 26 Dec 2026. Fees: 30 - 400 USD. Organizer: iPHARMA Conferences.
This significant conference aims to enhance understanding of proteasome modulation's role in disease treatment. Researchers and clinicians are invited to present their latest findings on how proteasome activity affects various diseases, including insights into its molecular pathways and therapeutic applications. A range of formats, including original research presentations, workshops, and poster sessions, will allow participants to exchange ideas and foster collaboration in this critical field of study. Attendees can look forward to keynotes from experts in proteasome biology, interactive discussions, and networking opportunities tailored for building partnerships among researchers and industry professionals. Contributions should focus on recent advancements, novel methodologies, and clinical implications tied to proteasome modulation. This is a unique chance to contribute to a dialogue that explores emerging strategies for disease treatment through proteasome research, enhancing collaborative efforts for impactful health solutions.